Growing community of inventors

Shanghai, China

Hongfu Lu

Average Co-Inventor Count = 5.57

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Hongfu LuHaibing Guo (4 patents)Hongfu LuWeiqiang Xing (4 patents)Hongfu LuJianbiao Peng (4 patents)Hongfu LuFeng Ren (3 patents)Hongfu LuBaojian Qi (3 patents)Hongfu LuXichen Lin (2 patents)Hongfu LuTing Yang (2 patents)Hongfu LuZhongmiao Xu (2 patents)Hongfu LuWeichun Chen (2 patents)Hongfu LuYongcong Lv (2 patents)Hongfu LuPaul Bryan Wren (2 patents)Hongfu LuEbere F Igboko (2 patents)Hongfu LuXiao Ding (1 patent)Hongfu LuHuaxing Yu (1 patent)Hongfu LuLindong Zhu (1 patent)Hongfu LuLingdong Zhu (1 patent)Hongfu LuWeichun Chen (0 patent)Hongfu LuXichen Lin (0 patent)Hongfu LuHongfu Lu (7 patents)Haibing GuoHaibing Guo (15 patents)Weiqiang XingWeiqiang Xing (10 patents)Jianbiao PengJianbiao Peng (9 patents)Feng RenFeng Ren (23 patents)Baojian QiBaojian Qi (3 patents)Xichen LinXichen Lin (22 patents)Ting YangTing Yang (8 patents)Zhongmiao XuZhongmiao Xu (4 patents)Weichun ChenWeichun Chen (4 patents)Yongcong LvYongcong Lv (3 patents)Paul Bryan WrenPaul Bryan Wren (2 patents)Ebere F IgbokoEbere F Igboko (2 patents)Xiao DingXiao Ding (14 patents)Huaxing YuHuaxing Yu (1 patent)Lindong ZhuLindong Zhu (1 patent)Lingdong ZhuLingdong Zhu (1 patent)Weichun ChenWeichun Chen (0 patent)Xichen LinXichen Lin (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Shanghai Jemincare Pharmaceuticals Co., Ltd. (3 from 6 patents)

2. Jiangxi Jemincare Group Co., Ltd. (3 from 6 patents)

3. Glaxosmithkline Intellectual Property Development Limited (2 from 230 patents)

4. Genentech, Inc. (1 from 3,222 patents)

5. Insilico Medicine IP Limited (1 from 37 patents)


7 patents:

1. 12441706 - Protein degradation agent compound preparation method and application

2. 12234223 - Phthalazinone compound, and preparation method therefor and medical use thereof

3. 12195457 - Aromatic ring derivative as immunoregulation and preparation method and application of aromatic ring derivative

4. 12077538 - Diacylglycerol kinase (DGK) alpha inhibitors and uses thereof

5. 11767312 - Phthalazinone compound, and preparation method therefor and medical use thereof

6. 10336719 - 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

7. 10106515 - 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/24/2025
Loading…